Lenva 4mg Capsule

About Lenva 4mg Capsule

Lenva 4mg Capsule is used to treat Thyroid cancer with capsules containing an oral receptor tyrosine kinase inhibitor. Your doctor will calculate the appropriate dosage for you depending on your treatment needs.

Many medications can interact with Lenva 4mg Capsule, so let your doctor know if you have any heart, liver, or renal problems or if you're on any antiviral treatments. Effective contraception is necessary for both males and females throughout therapy to avoid pregnancy, and it is not advised during pregnancy or nursing.

Brand Name: Lenva

Composition: Lenvatinib

Mechanism of Action:

Targeting many receptor tyrosine kinases implicated in tumor angiogenesis, growth, and proliferation, lentinan is a kind of multi-kinase inhibitor. It prevents: Platelet-derived growth factor receptor (PDGFR), fibroblast growth factor receptors (FGFR1-4), and vascular endothelial growth factor receptors (VEGFR1, VEGFR2, and VEGFR3) KIT and RET. Lenvatinib aids in preventing tumor development and lowering the tumor's blood supply by obstructing these routes.

Uses:

• Thyroid cancer
• Renal cell carcinoma
• Hepatocellular Carcinoma

Side effects:

Hypertension

Fatigue

Diarrhea

Decreased appetite

Nausea

Vomiting

heart failure

Blood clots (thromboembolism)

Dosage and administration:

Can be taken with or without food. It is important to take the capsules whole and not to crush or chew them. The recommended dose for differentiated thyroid cancer is usually 24 mg once daily. For renal cell carcinoma and hepatocellular carcinoma, the dose may vary; typically, it starts at 18 mg once daily.